| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 726767 | Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-propylamino}ethane Bis(trifluoroacetate | 0.0152653588725063 | 0.22595029 |
| NSC 734307 | 3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide | 0.0152653588725063 | 0.24978936 |
| NSC 737342 | 6-(3-Azidopropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline | 0.0152653588725063 | 0.25663824 |
| NSC 746131 | PYR-41 | 0.0152653588725063 | 0.62012558 |
| NSC 750324 | Null | 0.0152653588725063 | 0.089531072 |
| NSC 757113 | METHOTREXATE(+/-) | 0.0152653588725063 | 0.049829323 |
| NSC 9706 | Triethylenemelamine | 0.0152653588725063 | 0.08323647 |
| NSC 112846 | N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid | 0.0152653588725064 | -0.00091760091 |
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.0152653588725064 | 0.096444292 |
| NSC 16258 | Null | 0.0152653588725064 | 0.31471273 |